Category: Cardiometabolic & Disease Risk
-
When the Most Common Liver Disease Became Treatable
MASLD can no longer be treated as a low-priority diagnosis of exclusion. It is a screenable, stratifiable, and increasingly treatable disease.
-
The Risk a Zero Calcium Score Cannot See
Lp(a) and CAC provide independent, additive prognostic information, and a favorable calcium score should refine, not override, the intensity of management.
-
The PCSK9 Inhibitor That Finally Fits in a Pill Bottle
Its significance lies less in a new mechanism than in a new delivery paradigm that could meaningfully expand access to potent LDL-C lowering.
-
When Dense Bones Break and the Scan Says Nothing
In T2DM, higher BMD and higher fracture risk can and do coexist. This paradox is a consequence of biology current frameworks fail to capture.
-
Lipoprotein (a) and the Cardiovascular Risk Your Blood Test Never Mentions
Lipoprotein(a) is preset at pathological levels in one in five people, yet largely invisible to standard clinical practice for more than half a century.